Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person5
WEALTHFRONT CORP
Company
CVS HEALTH Corp
Company
AdaptHealth Corp.
Company
DarioHealth Corp.
Company
Syra Health Corp
Company
Primary record10
WEALTHFRONT CORP filed 8-K
Item 8.01 Other Events. On October 20, 2026, the Board of Directors of Wealthfront Corporation (the “Company”) approved the repurchase of up to an additional $150.0 million of the Company’s common stock under the Company
WEALTHFRONT CORP filed 4
SEC form 4 filed by WEALTHFRONT CORP (CIK 1524566) on 2026-09-18.
WEALTHFRONT CORP filed 4
SEC form 4 filed by WEALTHFRONT CORP (CIK 1524566) on 2026-09-17.
WEALTHFRONT CORP filed 4
SEC form 4 filed by WEALTHFRONT CORP (CIK 1524566) on 2026-09-17.
WEALTHFRONT CORP filed 4
SEC form 4 filed by WEALTHFRONT CORP (CIK 1524566) on 2026-09-17.
WEALTHFRONT CORP filed 4
SEC form 4 filed by WEALTHFRONT CORP (CIK 1524566) on 2026-09-17.
WEALTHFRONT CORP filed 4
SEC form 4 filed by WEALTHFRONT CORP (CIK 1524566) on 2026-09-11.
WEALTHFRONT CORP filed 8-K
Item 2.02 Results of Operations and Financial Condition. On September 9, 2026, Wealthfront Corporation (the “Company”) issued a press release announcing its financial results for the second fiscal quarter ended July 31,
WEALTHFRONT CORP filed 4
SEC form 4 filed by WEALTHFRONT CORP (CIK 1524566) on 2026-08-19.
WEALTHFRONT CORP filed SCHEDULE 13G/A
on June 12, 2026. See Row 5 of cover page for each Reporting Person. See Row 6 of cover page for each Reporting Person. See Row 7 of cover page for each Reporting Person. See Row 8 of cover page for each Reporting Person